Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review

JAMA

Volumn 278, Issue 23, 1997, Pages 2093-2098

  Weaver, W Douglas ^a,l,p   Simes, R John ^b   Betriu, Amadeo ^c,m   Grines, Cindy L ^d,n   Zijlstra, Felix ^e   Garcia, Eulogio ^f,l   Grinfeld, Lilliana ^g   Gibbons, Raymond J ^h,o   Ribeiro, Expedito E ⁱ   DeWood, Marcus A ^j   Ribichini, Flavio ^k,l  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c HOSPITAL CLÍNIC   (Spain)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e HOSPITAL DE WEEZENLANDEN   (Netherlands)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^h MAYO CLINIC   (United States)

ⁱ Hospital Unicor   (Brazil)

^j Spokane Heart Research Foundation   (United States)

^k S CROCE E CARLE HOSPITAL   (Italy)

^l BOSTON SCIENTIFIC CORPORATION   (United States)

^m Bard USCI Boston Scientific

ⁿ Guidant and Scimed

^o DUPONT COMPANY   (United States)

^p HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DUTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HEART REINFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031456844     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.23.2093     Document Type: Review

References (42)

1. O'Neill W, Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986;314:812-818.
2. Zijlstra F, de Boer JM, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
3. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
4. Goldman L. Cost and quality of life. J Am Coll Cardiol. 1995;25(suppl):38S-41S.
5. de Boer MJ, van Hout BA, Liem AL, et al. A cost-effective analysis of primary coronary angioplasty vs thrombolysis for acute myocardial infarction. Am J Cardiol. 1995;76:830-833.
6. Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
7. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator. J Am Coll Cardiol. 1997;29:901-907.
8. Every N, Parsons L, Hlatky M, et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 1996;335:1253-1260.
9. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329:673-682.
10. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated versus hospital-initiated thrombolytic therapy. JAMA. 1993;270:1211-1216.
11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trials of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
12. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm-paradoxic or predictable? Circulation. 1993;88:296-306.
13. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction: the MITI Project Group. J Am Coll Cardiol. 1991;18:657-662.
14. Simes RJ, Topol EJ, Holmes DR Jr, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Circulation. 1995;91:1923-1928.
15. Gruppo Italiano per lo Studio Della Streptochinasi nell' Infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
16. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction. Lancet. 1994;343:311-322.
17. Elizaga J, Garcia EJ, Delcan JL, et al. Primary coronary angioplasty versus systemic thrombolysis in acute anterior myocardial infarction. Circulation. 1993;88(suppl I):I-411. Abstract.
18. DeWood MA. Direct PTCA vs intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. In: Proceedings from the Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI. Washington, DC: George Washington University: 1990:28-29.
19. Ribeiro EE, Silva LA, Carneiro R, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1993;22:376-380.
20. Michels KB, Yusef S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? Circulation. 1995;91:476-485.
21. Jhangiani AH, Jorgensen MB, Mansukhani PW, et al. Community practice of primary angioplasty for myocardial infarction. J Am Coll Cardiol. 1996;27: 61 A. Abstract.
22. Zahn R, Vogt A, Neuhaus KL, et al. Angioplasty in acute myocardial infarction in clinical practice. J Am Coll Cardiol. 1997;29:15A. Abstract.
23. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Experience with primary PTCA compared to alteplase in patients with acute myocardial infarction. Circulation. 1996;92(suppl I):I-138. Abstract.
24. Caputo RP, Lopez JJ, Stoler RC, et al. The effect of institutional experience on the outcome of primary angioplasty for acute MI. J Am Coll Cardiol. 1996;27 (suppl A):A-62. Abstract.
25. Ribichini F, Steffenino G, Dellavalle A, et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression: a single-center randomized study. J Am Coll Cardiol. 1996;27:A-221. Abstract.
26. Grinfeld L, Berrocal D, Belardi J, et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP). J Am Coll Cardiol. 1996;27:(suppl): A-222. Abstract.
27. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
28. Zijlstra F, Beukema W, Van't Hof A, et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1997; 29:908-912.
29. Garcia E, Elizaga J, Soriano J, et al. Primary angioplasty versus thrombolysis with t-PA in the anterior myocardial infarction. J Am Coll Cardiol. 1997; 29(suppl A):A-389. Abstract.
30. Akhras F, Ousa AA, Swann G, et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? acute and late follow-up results in a new cardiac unit. J Am Coll Cardiol. 1997;29(suppl A):A-235-A-236. Abstract.
31. Mehta CR, Patel NR, Gray R. On computing an exact confidence interval for the common odds ratio in several 2×2 contingency tables. J Am Stat Assoc. 1984;80:969-973.
32. Mehta CR, Walsh SJ. Comparison of exact, mid-p and Mantel-Haenszel confidence intervals for the common odds ratio across several 2×2 contingency tables. Am Stat. 1992;46:146-150.
33. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
34. Zelen M, The analysis of several 2×2 contingency tables. Biometrika. 1971;58:129-137.
35. Mehta C, Patel N. Statistical Software for Exact Nonparametric Inference (StatXact). Cambridge, Mass: Cytel Software Corp; 1991.
36. Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Stat Med. 1987;6:11-29.
37. Berlin JA, BeggCB, Louis TA. An assessment of publication bias using a sample of published clinical trials. J Am Stat Assoc. 1989;84:381-392.
38. Stone GW, Grines CL, Browne KF, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol. 1995;26:66-72.
39. Mark D, O'Neill W, Brodie B, et al. Baseline and 6-months costs of primary angioplasty therapy for acute myocardial infarction: results from the Primary Angioplasty Registry. J Am Coll Cardiol. 1995;26: 688-695.
40. O'Keefe JO, Bailey WL, Rutherford BD, et al. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol. 1993;72: 107G-115G.
41. Cannon CP, Lambrew CT, Tiefenbrunn AJ, et al. Influence of door-to-balloon time on mortality in primary angioplasty results in 3,648 patients in the second National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996;27(suppl A):A-61. Abstract.
42. Stone GW, Brodie B, Griffin J, et al. Should the risk of delaying reperfusion prohibit inter-hospital transfer to perform primary PTCA in acute myocardial infarction? Circulation. 1996;94(suppl 1):I-331. Abstract.